Recent Media Coverage
Q1 2012
-
The Scientist: Top Ten Innovations 2011
Q4 2011
- Drug Discovery News: RainDance Technologies and Ambry Genetics Launch New DNA Sequencing Panel for ADME Research
- Chemistry & Biology: Next Generation Technology Edges Genome Sequencing toward the Clinic
- Genome Technology: qPCR Goes Plural
- Genome Technology: Next-Gen Tools Have Near-Term Applications in the Clinic, Companies Say
- BioTechniques: Future Methods in PCR
- Clinical Sequencing News: Emory Team Taps RainDance Amplification Method to Target X-Chromosome Exome for ASD Studies
- Clinical Sequencing News: New Products: ADMESeq
- SelectScience: RainDance Launches ThunderStorm System
- Drug Discovery & Development: ThunderStorm: Targeted Sequencing System
- Science: qPCR Innovations and Blueprints
- In Sequence: RainDance Preps Launch of ThunderStorm High-Throughput Target Enrichment Platform
Q3 2011
-
Genetic Engineering & Biotechnology News: Ambry Purchases RainDance’s ThunderStorm System for Targeted Sequencing
-
In Sequence: Ambry to Use New RainDance Enrichment System for Targeted Sequencing
-
PCR Insider: RainDance Eyes Early 2012 for Digital PCR Launch; Preps New Sequence Enrichment Platform for ASHG
- ScienceDaily: Droplets for Detecting Tumoral DNA
Q2 2011
- eLab: Focus On Enhanced Assays to Detect Cancer Cells
- PCR Insider: RainDance and Sony Co-Develop Consumable Microdroplet Chips for Life Science Apps [Subscription required]
- In Sequence: RainDance Technologies Has Released Its HeatWave Chip [Subscription required]
- GenomeWeb: RainDance, Sony Co-develop Consumable Microdroplet Chips
- BioTechniques: Enrichment Strategies Not All Equal
- PCR Insider: Publications Demonstrate Multiplexing, Clinical Potential of RainDance Digital PCR Tech
- G.I.T. Laboratory Journal: Cancer Diagnostics in Microscopic Droplets
- BioSpace: RainDance Technologies Names Andy Watson Vice President and Chief Marketing Officer
- The Daily Scan: This Week in PLoS: Comparison of Three Targeted Enrichment Strategies
- Genetic Engineering News: New Cancer Research Tools Change Paradigm
- Genome Technology: Short Reads: RainDance Technologies launches HLA panel [Subscription required]
- Drug Discovery News: Teaming Up To Interrogate Genes About ADME
- Genetic Engineering News: New Products: DeepSeq FFPE Solution
- Drug Discovery News: Genetic Screening Tools For Autism Spectrum Disorders
- Drug Discovery & Development: HLA Research Screening Panel
- LaboratoryTalk: Screening Panel Enables HLA And MHC Research
- CAP Today: Next-Gen Sequencing In Clinical Debuts
Q1 2011
- Bio-IT World: RainDance and Ambry Announced ADME Solution
- Boston Business Journal: People on the Move: Laura Deming [Subscription required]
- Mass High Tech: Mass. Tech Companies Report $125.8M Invested In One Week
- GenomeWeb: RainDance Technologies Has Tapped Andy Watson
- Clinical Sequencing News: RainDance, Emory University Launch Sequencing Panels for Autism and X-Linked Mutations [Subscription required]
- Drug Discovery & Development: RainDance-Ambry Collaborate on ADME for NGS
- In Sequence: RainDance to Co-Develop Next-Gen Sequencing Products for ADME Applications with Ambry and Roche
- GenomeWeb: RainDance Inks Deals with 454, Ambry Targeting ADME Applications
- SelectScience: Roche and RainDance Technologies Join Forces in Targeted Sequencing to Advance ADME Research
- Drug Discovery & Development: Roche, RainDance Collaborate in Targeted Sequencing for ADME Research
- Genetic Engineering News: RainDance Forges Separate Pacts with Ambry and Roche to Advance ADME Analysis
- In Sequence: Pacific Biosciences Adds 13 Partners for Ancillary Products, Services [Subscription required]
- Xconomy: Bay State Startup Funding Booms to $242.5M in January; Healthcare Firms Lead the Way
- In Sequence: RainDance Launches Targeted FFPE Sequencing Products; Partners with NuGen on Sample Prep [Subscription required]
- BIOspektrum: Sequenzierungslösung für FFPE-Proben
- Medical Device Daily: DeepSeq FFPE [Subscription required]
- Drug Discovery & Development: RainDance's DeepSeq FFPE Solution
- PCR Insider: RainDance Technologies Launches The DeepSeq FFPE Solution [Subscription required]
- BioCentury: Making It Rain [Subscription required]
- PCR Insider: Digital PCR a Priority for RainDance Following $37.5M Financing [Subscription required]
- Wall Street Journal/VC Dispatch: Start-ups Dabbling in the DNA Sequencing Field Continue to Reap Big Money
- Dow Jones VentureWire: RainDance Showered With $37.5M Series D for DNA Sequencing [Subscription required]
- Bio-IT World: RainDance Closes $37.5 Million in Financing
- Xconomy: RainDance Raises $37.5M
- Mass Device: Funding Roundup: RainDance Technologies Drums Up $37.5 Million
- In Sequence: RainDance Raises $37.5M, Plans to Expand into Medical Genetics Market [Subscription required]
- Genetic Engineering News: RainDance Pockets 37.5M in Series D Financing
- G.I.T. Laboratory Journal: Series D Financing Round Closed
- MDT: RainDance Technologies Raises $38M Funding Round
